RAFAEL HOLDINGS, INC. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
RAFAEL HOLDINGS, INC. (RFL) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $257.00 thousand for the 9-month period ending 2025-04-30, per its 10-Q filed 2025-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2025-06-11
- RAFAEL HOLDINGS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-01-31 was -$2.29M.
- RAFAEL HOLDINGS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2024-10-31 was $2.55M, a 1.88% increase year-over-year.
- RAFAEL HOLDINGS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2023-10-31 was $2.50M.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month |
|---|---|---|---|
| 2025-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$2.29M derived: sum of 2 quarters · filed 2025-06-11 | $257.00K 10-Q · filed 2025-06-11 |
| 2025-01-31 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $257.00K 10-Q · filed 2025-03-14 | |
| 2024-10-31 | $2.55M 10-Q · filed 2024-12-11 | ||
| 2023-10-31 | $2.50M 10-Q · filed 2024-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |